Compare OSK & RDY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OSK | RDY |
|---|---|---|
| Founded | 1917 | 1984 |
| Country | United States | India |
| Employees | N/A | N/A |
| Industry | Auto Manufacturing | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 9.4B | 9.9B |
| IPO Year | 2009 | 2001 |
| Metric | OSK | RDY |
|---|---|---|
| Price | $157.91 | $12.28 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 14 | 1 |
| Target Price | ★ $166.79 | $16.90 |
| AVG Volume (30 Days) | 734.0K | ★ 2.6M |
| Earning Date | 05-08-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.55% | 0.52% |
| EPS Growth | N/A | N/A |
| EPS | ★ 1.14 | N/A |
| Revenue | ★ $7,705,500,000.00 | N/A |
| Revenue This Year | $5.94 | $7.72 |
| Revenue Next Year | $7.19 | $3.50 |
| P/E Ratio | $136.17 | ★ $18.67 |
| Revenue Growth | ★ 12.83 | N/A |
| 52 Week Low | $116.77 | $11.36 |
| 52 Week High | $180.49 | $15.67 |
| Indicator | OSK | RDY |
|---|---|---|
| Relative Strength Index (RSI) | 58.79 | 45.56 |
| Support Level | $138.41 | $12.09 |
| Resistance Level | $158.91 | $12.58 |
| Average True Range (ATR) | 4.41 | 0.20 |
| MACD | 0.10 | 0.06 |
| Stochastic Oscillator | 82.40 | 62.50 |
Oshkosh is a leading maker of access equipment, specialty vehicles, and military trucks. It serves diverse end markets, including postal, firefighting, refuse/recycling collection, aviation, and construction. It is typically the market share leader or No. 2 player in North America, or even the global leader in the case of its JLG aerial work platform business. The transport segment is a leading provider of light trucks to the military and vehicles to the Postal Service. The vocational segment, featuring brands such as Pierce, AeroTech, and Volterra, offers purpose-built vehicles and equipment to municipalities. The company reports three segments—Access equipment (45% of revenue), Vocational (35%), and Transport (20%) on 2025 revenue of $10.4 billion.
Dr. Reddy's is one of the largest generic drug manufacturers in the world. It has a significant presence in North America, a region that makes up roughly 40% of its generics sales, with other key markets being India (20%) and Europe (20%). Beyond simple generics, Dr. Reddy's also has a solid portfolio of injectables which make up 25% of its North America sales. In branded generic markets like India, Dr. Reddy's has established a compelling presence with its strong brand name and earned a top five spot in key therapeutic areas including oncology and gastroenterology. Dr. Reddy's also has an active pharmaceutical ingredient business that manufactures over 150 APIs and sells in over 75 countries.